Snake Venom is a modern hybrid-indica strain whose exact origins and complete lineage remain undocumented. Breeders have not publicly confirmed the cross, and while some reports associate its genetic history with Original Glue, the broader context of its development remains unverified. Given the lack of a formal breeder description, its precise provenance exists as an open question within the cannabis community, leaving its emergence as a largely mysterious entry in the modern market.

The terpene profile of Snake Venom is complex, featuring a confirmed hierarchy of caryophyllene, limonene, myrcene, humulene, bisabolol, terpinolene, linalool, and beta-pinene. This chemical makeup is characterized by a significant presence of caryophyllene and limonene, which likely dictate its distinct aromatic and flavor qualities. With an estimated THC content of approximately 9.6% and negligible concentrations of CBD and CBG, the strain offers a predictable, modest potency profile compared to high-test market varieties.

Users seek out Snake Venom primarily for its observed ability to induce a state of relaxation while maintaining mental focus. These effects make it a functional choice for managing physical pain, alleviating stress, or assisting with sleep. The strain is suitable for both indoor and outdoor cultivation, boasting a flowering time of 55 days and a high yield potential for those of moderate growing experience. To date, there are no notable offspring recorded for this variety.